Community health workers may help south asians with diabetes fight depression

NCT ID NCT07219667

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 38 times

Summary

This study will adapt a community health worker-led program to include mental health and digital tools for South Asians with type 2 diabetes who are at risk for depression. Researchers will test whether the program is feasible and acceptable to participants. The study involves 100 adults in New York City and measures changes in blood sugar levels, diabetes distress, and depressive symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • NYU Langone Health

    New York, New York, 10016, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

community health worker-led behavioral intervention with mental health and digital components

What this could lead to

If successful, this could provide a practical, culturally tailored support program to help South Asians with type 2 diabetes manage their condition and reduce depression risk.

What could go wrong

This is a small, early feasibility study with only 100 participants, so results may not apply broadly. The intervention is behavioral and may not produce significant medical changes.

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.